Categories: News

123Invent Inventor Develops Sensor-Activated Motorized Toilet (FJK-608)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PITTSBURGH, May 21, 2025 /PRNewswire/ — “I wanted to create a new toilet that can adapt to each individual user for optimal comfort and safety,” said an inventor, from Palm Bay, Fla., “so I invented the SAM- T. My smart design assists users in any stage of life.”

The invention provides an improved toilet designed to adapt to the individual user’s needs. In doing so, it increases comfort, convenience, safety, efficiency, and independence. It also eliminates the need to touch the toilet seat when raising or lowering it, and it ensures the toilet is clean for every use. The invention features an adjustable and innovative design that is easy to use, and it is ideal for individuals with physical disabilities or limited mobility, patients after surgery, etc.

The SAM- T is currently available for licensing or sale to manufacturers or marketers. For more information, visit www.sam-t.com. Or contact Dajaye Jenkins at 352-209-7740 or email info@sam-t.com.

CisionCision View original content to download multimedia:https://www.prnewswire.com/news-releases/123invent-inventor-develops-sensor-activated-motorized-toilet-fjk-608-302460140.html

SOURCE InventHelp

Staff

Recent Posts

H1 25 Results: Increased Profitability Despite Subdued Revenues

Ad hoc announcement pursuant to Art. 53 LR MEDIA RELEASE Baar, Switzerland--(Newsfile Corp. - July…

4 hours ago

NEWBEAUTY RELEASES ‘THE STATE OF AESTHETICS: BY THE NUMBERS SUMMER 2025’

CRANBURY, N.J., July 22, 2025 /PRNewswire/ -- NewBeauty , the definitive authority on all things beauty, has announced…

11 hours ago

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules

SAN DIEGO and CALGARY, AB, July 22, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC)…

11 hours ago

Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as Company Prepares Public Launch

Veteran pharma operator co-founded Ategenos to tackle the global $1 trillion crisis of medication non-adherence…

11 hours ago